check_circleStudy Completed
Postmenopause, Hormone Replacement Therapy
Bayer Identifier:
SDG_2004.04
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Observational Trial Angeliq
Trial purpose
Please see attached Study Results Summary below.
Key Participants Requirements
Sex
N/AAge
N/ATrial summary
Enrollment Goal
818Trial Dates
August 2004 - July 2005Phase
N/ACould I Receive a placebo
N/AProducts
Angeliq (E2/DRSP, BAY86-4891)Accepts Healthy Volunteer
N/APrimary Outcome
Secondary Outcome
Trial design
Trial Type
ObservationalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A